Port-a-Cath-related complications in 252 patients with solid tissue tumours and the first report of heparin-induced delayed hypersensitivity after Port-a-Cath heparinisation
Author:
Publisher
Wiley
Subject
Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ecc.12008/fullpdf
Reference25 articles.
1. Totally implantable central venous access ports. Analysis of 700 cases;Barbetakis;Journal of Surgical Oncology,2011
2. Bard Access Systems 2003 Implanted Ports with Open-Ended Catheters. Instructions for use
3. Heparin-induced recurrent anaphylaxis;Berkun;Clinical and Experimental Allergy,2004
4. Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients;Biffi;Annals of Oncology,2004
5. Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial;Biffi;Annals of Oncology,2009
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Complications and Management Strategies of Totally Implantable Venous Access Devices;Medical Diagnosis;2023
2. Heparin versus normal saline locking for prevention of occlusion, catheter-related infections and thrombosis in central venous catheter in adults: Overview of systematic reviews;The Journal of Vascular Access;2022-06-10
3. A totally implantable venous access device (TIVAD) abandoned for 5 years is re-accessed normally: A case report and literature review;The Journal of Vascular Access;2021-08-16
4. Heparin versus 0.9% saline solution to maintain patency of totally implanted venous access ports in cancer patients: A systematic review and meta‐analysis;International Journal of Nursing Practice;2021-01-22
5. Heparin flush vs. normal saline flush to maintain the patency of central venous catheter among adult patients: A systematic review and meta-analysis;Journal of Family Medicine and Primary Care;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3